Development of an Enzyme-Linked Immunosorbent Spot Assay for the Assessment of Adeno-Associated Virus Peptides to Examine Immune Safety
Human Gene Therapy · 2024
DOI: 10.1089/hum.2023.180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy, 2024. Verfasst von Sara Rose Krivoshik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Non-Clinical Drug Safety, Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA. Hauptthemen laut MEDLINE: Dependovirus, Enzyme-Linked Immunospot Assay, Genetic Vectors, Interferon-gamma. Die Arbeit nennt 56 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Non-Clinical Drug Safety, Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA.
- Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA.
ORCID-Profile: Sara Rose Krivoshik
Zitieren
APA
Krivoshik, S. R., Dzielak, L., Masters, A. R., Hall, J., & Johnson, A. J. (2024). Development of an Enzyme-Linked Immunosorbent Spot Assay for the Assessment of Adeno-Associated Virus Peptides to Examine Immune Safety. Human Gene Therapy. https://doi.org/10.1089/hum.2023.180
Vancouver
Krivoshik SR, Dzielak L, Masters AR, Hall J, Johnson AJ. Development of an Enzyme-Linked Immunosorbent Spot Assay for the Assessment of Adeno-Associated Virus Peptides to Examine Immune Safety. Human Gene Therapy. 2024. doi:10.1089/hum.2023.180
BibTeX
@article{Krivoshik2024,
author = {Krivoshik, Sara Rose and Dzielak, Lindsey and Masters, April R and Hall, Jennifer and Johnson, Alison J},
title = {Development of an Enzyme-Linked Immunosorbent Spot Assay for the Assessment of Adeno-Associated Virus Peptides to Examine Immune Safety},
journal = {Human Gene Therapy},
year = {2024},
doi = {10.1089/hum.2023.180}
}
EUVIMED